Senti Biosciences

Senti Biosciences

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.15-$2.48
Market Cap
$8.3M
Shares Short
427,404

Financials

See more
Revenue (12 Mos)
$55,000
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
-$31.2M
Diluted EPS
-$1.72

News

See more

Yahoo Finance • 4 months ago

Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™ Technology Platform

Yahoo Finance • 11 months ago

BC-Most Active Stocks

Yahoo Finance • 11 months ago

Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Society of Hematology (ASH) Annual Meeting 2025 on Tuesday, December 9th at 8:00 AM ET

Yahoo Finance • 12 months ago

Senti Biosciences GAAP EPS of -$0.69 misses by $0.12

About

CEO
Dr. Timothy K. Lu M.D., Ph.D.
Address
2 Corporate Drive, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
39